The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases
Open accessAbstract
CONTEXT: Although tumor necrosis factor (TNF)-α antagonists are increasingly used in place of nonbiologic comparator medications, their safety profile remains incomplete. OBJECTIVES: To determine whether initiation of TNF-α antagonists compared with nonbiologic comparators is associated with an increased risk of serious infections requiring hospitalization. DESIGN, SETTING, AND PATIENTS: Within a US multi-institutional collaboration, we assembled retrospective cohorts (1998-2007) of patients with rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and psoriasis, psoriatic arthritis, or ankylosing spondylitis (psoriasis and spondyloarthropathies) combining data from Kaiser Permanente Northern California, New Jersey and Pennsylvania Pharmaceutical Assistance programs, Tennessee Medicaid, and national Medicaid/Medicare. TNF-α antagonists and nonbiologic regimens were compared in disease-specific propensity score (PS)-matched cohorts using Cox regression models with nonbiologics as the reference. Baseline glucocorticoid use was evaluated as a separate covariate. MAIN OUTCOME MEASURE: Infections requiring hospitalization (serious infections) during the first 12 months after initiation of TNF-α antagonists or nonbiologic regimens. RESULTS: Study cohorts included 10,484 RA, 2323 IBD, and 3215 psoriasis and spondyloarthropathies matched pairs using TNF-α antagonists and comparator medications. Overall, we identified 1172 serious infections, most of which (53%) were pneumonia and skin and soft tissue infections. Among patients with RA, serious infection hospitalization rates were 8.16 (TNF-α antagonists) and 7.78 (comparator regimens) per 100 person-years (adjusted hazard ratio [aHR], 1.05 [95% CI, 0.91-1.21]). Among patients with IBD, rates were 10.91 (TNF-α antagonists) and 9.60 (comparator) per 100 person-years (aHR, 1.10 [95% CI, 0.83-1.46]). Among patients with psoriasis and spondyloarthropathies, rates were 5.41 (TNF-α antagonists) and 5.37 (comparator) per 100 person-years (aHR, 1.05 [95% CI, 0.76-1.45]). Among patients with RA, infliximab was associated with a significant increase in serious infections compared with etanercept (aHR, 1.26 [95% CI, 1.07-1.47]) and adalimumab (aHR, 1.23 [95% CI, 1.02-1.48]). Baseline glucocorticoid use was associated with a dose-dependent increase in infections. CONCLUSION: Among patients with autoimmune diseases, compared with treatment with nonbiologic regimens, initiation of TNF-α antagonists was not associated with an increased risk of hospitalizations for serious infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Robust Inference for the Cox Proportional Hazards Model
Lin, D. Y., & Wei, L. J. (1989) · Journal of the American Statistical Association · doi:10.1080/01621459.1989.10478874 · Cited by 2,695
Bongartz, T., Sutton, A. J., Sweeting, M. J., Buchan, I., Matteson, E. L., & Montori, V. (2006) · JAMA · doi:10.1001/jama.295.19.2275 · Cited by 2,468
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
Checking the Cox model with cumulative sums of martingale-based residuals
LIN, D. Y., WEI, L. J., & YING, Z. (1993) · Biometrika · doi:10.1093/biomet/80.3.557 · Cited by 1,432
Doran, M. F., Crowson, C. S., Pond, G. R., O'Fallon, W. M., & Gabriel, S. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10524 · Cited by 1,214
Saag, K. G., Teng, G. G., Patkar, N. M., Anuntiyo, J., Finney, C., Curtis, J. R., Paulus, H. E., Mudano, A., Pisu, M., Elkins‐Melton, M., et al. (2008) · Arthritis Care & Research · doi:10.1002/art.23721 · Cited by 1,157
Self-citationSample-Size Formula for the Proportional-Hazards Regression Model
Schoenfeld, D. A. (1983) · Biometrics · doi:10.2307/2531021 · Cited by 1,096
Risk of Infectious Complications in Patients Taking Glucocorticosteroids
Stuck, A. E., Minder, C. E., & Frey, F. J. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.6.954 · Cited by 836
Dixon, W. G., Watson, K., Lunt, M., Hyrich, K. L., Silman, A. J., & Symmons, D. P. M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21978 · Cited by 751
Infections in patients with rheumatoid arthritis treated with biologic agents
Listing, J., Strangfeld, A., Kary, S., Rau, R., von Hinueber, U., Stoyanova‐Scholz, M., Gromnica‐Ihle, E., Antoni, C., Herzer, P., Kekow, J., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21386 · Cited by 681
Galloway, J. B., Hyrich, K. L., Mercer, L. K., Dixon, W. G., Fu, B., Ustianowski, A. P., Watson, K. D., Lunt, M., BSRBR Control Centre Consortium, Symmons, D. P. M., et al. (2011) · Rheumatology · doi:10.1093/rheumatology/keq242 · Cited by 676
Peyrin–Biroulet, L., Deltenre, P., de Suray, N., Branche, J., Sandborn, W. J., & Colombel, J. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.03.014 · Cited by 577
Predictors of infection in rheumatoid arthritis
Doran, M. F., Crowson, C. S., Pond, G. R., O'Fallon, W. M., & Gabriel, S. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10529 · Cited by 560
Buttgereit, F., Da Silva, J. A. P., Boers, M., Burmester, G.-R., Cutolo, M., Jacobs, J., Kirwan, J., Köhler, L., van Riel, P., Vischer, T., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.8.718 · Cited by 544
Wolfe, F., Caplan, L., & Michaud, K. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21568 · Cited by 480
Askling, J., Fored, C. M., Brandt, L., Baecklund, E., Bertilsson, L., Cöster, L., Geborek, P., Jacobsson, L. T., Lindblad, S., Lysholm, J., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21137 · Cited by 419
Curtis, J. R., Patkar, N., Xie, A., Martin, C., Allison, J. J., Saag, M., Shatin, D., & Saag, K. G. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22504 · Cited by 398
Self-citationSolomon, D. H. (2011) · JAMA · doi:10.1001/jama.2011.878 · Cited by 393
Self-citationSample-Size Calculations for the Cox Proportional Hazards Regression Model with Nonbinary Covariates
Hsieh, F. Y., & Lavori, P. W. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00104-5 · Cited by 371
Leombruno, J. P., Einarson, T. R., & Keystone, E. C. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.091025 · Cited by 362
Au, K., Reed, G., Curtis, J. R., Kremer, J. M., Greenberg, J. D., Strand, V., & Furst, D. E. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.128637 · Cited by 337
Self-citationAskling, J., Fored, C. M., Brandt, L., Baecklund, E., Bertilsson, L., Feltelius, N., Cöster, L., Geborek, P., Jacobsson, L. T., Lindblad, S., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062760 · Cited by 334
USE OF MEDICAID DATA FOR PHARMACOEPIDEMIOLOGY
RAY, W. A., & GRIFFIN, M. R. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115198 · Cited by 315
Self-citationDixon, W. G., Symmons, D. P. M., Lunt, M., Watson, K. D., Hyrich, K. L., & Silman, A. J. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22808 · Cited by 307
Schneeweiss, S., Setoguchi, S., Weinblatt, M. E., Katz, J. N., Avorn, J., Sax, P. E., Levin, R., & Solomon, D. H. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22600 · Cited by 302
Self-citationThe Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
Furst, D. E. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.10.002 · Cited by 291
The risk of hospitalized infection in patients with rheumatoid arthritis.
Smitten, A. L., Choi, H. K., Hochberg, M. C., Suissa, S., Simon, T. A., Testa, M. A., & Chan, K. A. (2008) · PubMed · Cited by 281
Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis
Bernatsky, S., Hudson, M., & Suissa, S. (2007) · Rheumatology · doi:10.1093/rheumatology/kem076 · Cited by 281
Greenberg, J. D., Reed, G., Kremer, J. M., Tindall, E., Kavanaugh, A., Zheng, C., Bishai, W., & Hochberg, M. C. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.089276 · Cited by 275
SCHNEEWEISS, S., KORZENIK, J., SOLOMON, D. H., CANNING, C., LEE, J., & BRESSLER, B. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04037.x · Cited by 216
Self-citationSolomon, D. H., Avorn, J., Katz, J. N., Weinblatt, M. E., Setoguchi, S., Levin, R., & Schneeweiss, S. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22255 · Cited by 181
Self-citationVeteran’s affairs hospital discharge databases coded serious bacterial infections accurately
Schneeweiss, S., Robicsek, A., Scranton, R., Zuckerman, D., & Solomon, D. H. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.07.011 · Cited by 178
Self-citationSchmajuk, G., Trivedi, A. N., Solomon, D. H., Yelin, E. H., Trupin, L. S., Chakravarty, E. F., & Yazdany, J. (2011) · JAMA · doi:10.1001/jama.2011.67 · Cited by 132
Self-citationCurtis, J. R., Xie, F., Chen, L., Baddley, J. W., Beukelman, T., Saag, K. G., Spettell, C. M., Mcmahan, R. M., Fernandes, J., Winthrop, K. L., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146365 · Cited by 119
Self-citationChecking the Cox Model with Cumulative Sums of Martingale-Based Residuals
Lin, D. Y., Wei, L. J., & Ying, Z. (1993) · Biometrika · doi:10.2307/2337177 · Cited by 103
Glucocorticoids in the treatment of early and late RA
Bijlsma, J. W. J., Boers, M., Saag, K. G., & Furst, D. E. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.11.1033 · Cited by 101
Self-citationCurtis, J. R., Xi, J., Patkar, N. M., Xie, A., Saag, K. G., & Martin, C. K. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23050 · Cited by 93
Self-citationFouque-Aubert, A., Jette-Paulin, L., Combescure, C., Basch, A., Tebib, J.-G., & Gossec, L. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.098822 · Cited by 91
Lane, M., McDonald, J. R., Zeringue, A., Caplan, L., Curtis, J. R., Ranganathan, P., & Eisen, S. A. (2011) · Medicine · doi:10.1097/md.0b013e318211106a · Cited by 86
Self-citationPatkar, N. M., Curtis, J. R., Teng, G. G., Allison, J. J., Saag, M. S., Martin, C. K., & Saag, K. G. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.06.006 · Cited by 79
Self-citationChanging patterns of medication use in patients with rheumatoid arthritis in a Medicaid population
Grijalva, C. G., Chung, C. P., Stein, C. M., Mitchel, E. F., & Griffin, M. R. (2008) · Lara D. Veeken · doi:10.1093/rheumatology/ken193 · Cited by 78
Self-citationInitiation of rheumatoid arthritis treatments and the risk of serious infections
Grijalva, C. G., Kaltenbach, L. A., Arbogast, P. G., Mitchel, E. F., & Griffin, M. R. (2009) · Rheumatology · doi:10.1093/rheumatology/kep325 · Cited by 76
Self-citationRigby, W. F. C. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0438 · Cited by 69
Grijalva, C. G., Chung, C. P., Stein, C. M., Gideon, P. S., Dyer, S. M., Mitchel, E. F., & Griffin, M. R. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1625 · Cited by 58
Self-citationYu, O., Nelson, J. C., Bounds, L., & Jackson, L. A. (2010) · Epidemiology and Infection · doi:10.1017/s0950268810002529 · Cited by 45
Solomon, D. H., Lunt, M., & Schneeweiß, S. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23396 · Cited by 42
Self-citationRassen, J. A., Solomon, D. H., Curtis, J. R., Herrinton, L. J., & Schneeweiß, S. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181d59541 · Cited by 39
Self-citationHudson, M., & Suissa, S. (2010) · Arthritis Care & Research · doi:10.1002/acr.20124 · Cited by 37
Herrinton, L. J., Curtis, J. R., Chen, L., Liu, L., Delzell, E., Lewis, J. D., Solomon, D. H., Griffin, M. R., Ouellet‐Hellstrom, R., Beukelman, T., et al. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2196 · Cited by 33
Self-citationCurtis, J. R., Martin, C. K., Saag, K. G., Patkar, N. M., Kramer, J., Shatin, D., Allison, J. J., & Braun, M. M. (2007) · Arthritis Care & Research · doi:10.1002/art.22544 · Cited by 23
Self-citation
Cited by
Liu, D., Ahmet, A., Ward, L., Krishnamoorthy, P., Mandelcorn, E. D., Leigh, R., Brown, J. P., Cohen, A., & Kim, H. (2013) · Allergy, Asthma & Clinical Immunology · doi:10.1186/1710-1492-9-30 · Cited by 1,268
Ramiro, S., Gaujoux-Viala, C., Nam, J. L., Smolen, J. S., Buch, M., Gossec, L., van der Heijde, D., Winthrop, K., & Landewé, R. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204575 · Cited by 701
Self-citationSingh, J. A., Cameron, C., Noorbaloochi, S., Cullis, T., Tucker, M., Christensen, R., Ghogomu, E. T., Coyle, D., Clifford, T., Tugwell, P., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61704-9 · Cited by 623
Kirchgesner, J., Lemaitre, M., Carrat, F., Zureik, M., Carbonnel, F., & Dray-Spira, R. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.04.012 · Cited by 609
Burmester, G. R., Panaccione, R., Gordon, K. B., McIlraith, M. J., & Lacerda, A. P. M. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201244 · Cited by 591
Metadata
- Authors
- Grijalva, C. G., Chen, L., Delzell, E., Baddley, J. W., Beukelman, T., Winthrop, K. L., Griffin, M. R., Herrinton, L. J., Liu, L., Ouellet-Hellstrom, R., Patkar, N. M., Solomon, D. H., Lewis, J. D., Xie, F., Saag, K. G., & Curtis, J. R.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2011-12-07
- Volume
- 306
- Issue
- 21
- Pages
- 2331-9
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2014075805
- Cited by
- 350
- References
- 50
- FWCI
- 24.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.